Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00233467
Status:
WITHDRAWN
Last Update Posted:
2017-09-14
First Post:
2005-10-03
Brief Title:
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
Sponsor:
Tuscaloosa Research Education Advancement Corporation
Organization:
Tuscaloosa Research Education Advancement Corporation
Study Overview
Official Title:
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
Status:
WITHDRAWN
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Funding expired no subjects enrolled as this was a retrospective chart review
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten years worth of data from 1994 through 2004 We will also determine the type and dose of antipsychotics the patients received and to determine how many of those patients had psychotic versus nonpsychotic symptoms We will be obtaining this data from the VISN 7 Corporate Data Warehouse We hypothesize that there has been an overall increase in antipsychotic use in patients with PTSD over the last 10 years
Detailed Description:
This study is a retrospective chart review of patients at the Tuscaloosa VA Medical Center who were treated with antipsychotics as monotherapy or adjunctive therapy
The data will be retrieved from a computerized list of patients treated at the TVAMC for PTSD from 1994-2004 Charts will be reviewed by looking at approximately ten years worth of data Charts will then be examined to determine what type of antipsychotics patients were prescribed the dose and duration of the antipsychotics and the presence or absence of documented psychotic symptoms
The data will be retrieved from a computerized list of patients treated at the TVAMC for PTSD from 1994-2004 Charts will be reviewed by looking at approximately ten years worth of data Charts will then be examined to determine what type of antipsychotics patients were prescribed the dose and duration of the antipsychotics and the presence or absence of documented psychotic symptoms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None